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INTRODUCTION
The purine nucleoside analogs (NAs) cladribine (2-chloro-2'-deoxyadenosine, CdA) and fludarabine (9--D-arabinofuranosyl-2-fluoroadenine-5'-monophosphate) are effective drugs in indolent B-cell malignancies, including chronic lymphocytic leukemia (CLL) [1] [2] [3] . To exert their antileukemic effects, purine NAs require intracellular conversion to triphosphate compounds. This process takes place mainly in lymphoid cells that have a high ratio of deoxycytidine kinase to cytosolic 5'-nucleotidase. Once activated, the purine NAs induce cell death by apoptosis.
Several mechanisms have been put forth to explain the antileukemic activity of CdA and fludarabine. One mechanism is the inhibition of DNA synthesis, including replication and repair, leading to an accumulation of DNA strand breaks and activation of the p53 pathway [4, 5] . This process leads to the induction of pro-apoptotic genes, release of cytochrome c, and activation of the intrinsic pathway of apoptosis. In addition, purine NAs can promote apoptosis by p53-independent mechanisms. The triphosphate derivatives can bind to proteins located in the mitochondrial membrane, disrupting its permeability and causing the release of cytochrome c and apoptosis inducing factor (AIF) [6] . They also cooperate with cytochrome c and apoptosis protein-activated factor-1 (Apaf-1) to initiate the intrinsic pathway of apoptosis [7, 8] . Lastly, purine NAs, mainly fludarabine, inhibit RNA and protein synthesis, which could contribute to their cytotoxicity by reducing the synthesis of proteins that are essential for cell survival [9, 10] . The diversity of these effects can explain why purine NAs are efficient towards both proliferating and quiescent cells.
We previously investigated the effect of CdA in EHEB cells, a continuous cell line derived from CLL lymphocytes [11] with low sensitivity to CdA [12] . Analysis of the cell cycle showed that CdA accelerated the progression from G1 to S phase before inducing cell death [12, 13] . This cell response to CdA was unexpected because purine analogs are known
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As preliminary data indicated a lack of p21 accumulation in EHEB cells treated with CdA in spite of p53 induction [13] , we further investigated the p53-p21 axis in the CLL cell lines EHEB and JVM-2. We clearly demonstrate that not only CdA, but also fludarabine and pyrimidine analogs, can induce p21 depletion, while p53 is up-regulated. Furthermore, we
show that this decrease in p21 protein upon NA treatment is due to an increased proteasomal degradation, which had already been reported after selected DNA-damaging conditions, particularly UV irradiation [15] [16] [17] [18] , but never after NAs. We finally focus on the possible impact of this decrease in p21 protein level.
MATERIALS AND METHODS

Materials
CdA was synthesized and supplied by Prof. J. Marchand (Laboratory of Organic Chemistry, Université catholique de Louvain, Louvain-la-Neuve, Belgium). Stock solutions of CdA were prepared in 150 mM NaCl in ethanol (v/v). The nucleoside form of fludarabine (F-Ara-A, referred later to as fludarabine), gemcitabine (2',2'-difluoro-2'-deoxycytidine, dFdC),
histone H1, nutlin-3a, etoposide, and -actin (A5441) were purchased from Sigma-Aldrich (St Louis, MO, USA). Carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-fluoromethylketone (Z-VAD-fmk) was purchased from Alexis Biochemicals (San Diego, CA, USA). Antibodies other than -actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
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32-
PATP (10 mCi/ml) was purchased from Perkin-Elmer (Waltham, MA, USA). The protein A/G sepharose beads were from Oncogene Research Products (Cambridge, MA, USA).
Cell culture and incubations
The EHEB and JVM-2 cell lines were purchased from DSMZ-German Collection of
Microorganisms and Cell Culture (Braunschweig, Germany). Cells were cultured in RPMI-1640 medium with Glutamax supplemented with 10% heat-inactivated FCS at 37°C in humidified air containing 5% CO 2 . Peripheral blood from CLL patients was obtained after written informed consent in accordance with the hospital ethics committee. CLL lymphocytes were isolated and incubated as previously reported [19] . Inhibitors (MG-132, LLnL, Z-VADfmk) were added 30 min before NAs. Stock solutions of inhibitors were prepared in DMSO.
Cell lysis
After incubation, 2 to 4 x 10 6 cells (or 1 x 10 7 cells for Cdk2 assay) were pelleted by centrifugation at 1500 x g for 5 min and washed twice in ice-cold PBS. Cell pellets were resuspended in 70-250 µl of lysis buffer containing 20 mM HEPES (pH 7.9), 150 mM NaCl, 1 mM MgCl 2 , 5 mM EDTA (pH 8), 1% Nonidet P-40, 0.1% SDS, 50 mM NaF, and freshly added protease inhibitors (5 mM benzamidine, 1 mM p-toluenesulfonyl fluoride, 5 µg/ml leupeptin and antipain) and 1 mM orthovanadate, and lysed for 20 min on ice. Cell lysates were centrifuged at 16 000 x g for 10 min at 4°C, and the supernatants were stored at -20°C until use. Protein concentrations were determined by Bradford's method [20] , using BSA as the standard.
For proliferating cell nuclear antigen (PCNA) analysis, cell pellets (4 x 10 6 cells) were resuspended in 125 µl buffer A (10 mM HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.5% Nonidet P-40, 1 mM dithiothreitol, and protease inhibitors) and incubated for 10 min on ice 
Western blot analysis
Protein expression was analyzed by Western blot as previously described [19] . 7 performed as described above using anti-ubiquitin (sc-8017) and anti-p21 (sc-6246) as the primary antibodies.
Cdk2 activity
For each assay, 500 µg of protein extract was subjected to immunoprecipitation with 2 µg of anti-Cdk2 antibody (sc-163) and protein A/G sepharose beads. The beads were washed twice with lysis buffer and twice with kinase buffer (20 mM Tris-HCl pH 7.5, 0.1 mM EGTA pH 7.0, 10 mM MgCl 2 , and 1 mM dithiothreitol). Kinase reactions were carried out in 30 µl kinase buffer containing 1 µg of histone H1, 20 µM ATP, and 6 µCi of -32 PATP, as described in [22] . After 30 min at 37°C, 30 µl of 2X SDS sample loading buffer was added to terminate the reaction. The mixture was boiled for 5 min and centrifuged. Histone H1 was resolved on a 12% SDS-polyacrylamide gel and analyzed by autoradiography. In some experiments, the bands corresponding to histone H1 were revealed by Coomassie blue staining, cut out from the gel, and subjected to counting by Cerenkov radiation.
Quantitative real-time polymerase chain reaction (qPCR)
Total cellular RNA was prepared using TRIzol (Gibco/Invitrogen). One microgram of RNA was reverse transcribed with random hexamers according to the Fermentas (St Leon-Rot, Germany) protocol, and the cDNA was subsequently amplified by qPCR. The specific primers for p21 were from Eurogentec (Ougree, Belgium). All reactions were performed in duplicate in MyiQ or iCycler iQ systems (Bio-Rad, Hercules, CA, USA). The amplification was performed as recommended by the manufacturer (Eurogentec, Ougree, Belgium). PCR product specificity and genomic DNA contamination were verified by melting curve analysis and/or agarose gel electrophoresis. The relative quantification of p21 gene expression was performed using the 2 -CT method [23] . 18S expression was used as an endogenous control to normalize expression within each sample.
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Data analysis
The results of experiments repeated three times in the same conditions are given as the mean ± SEM. Significance was estimated by the paired two-tailed Student's t test. Changes were considered significantly different when P < 0.05.
RESULTS
CdA reduces the p21 protein level in EHEB cells despite functional integrity of the p53-p21 pathway
First, we analyzed the effect of CdA at concentrations ranging from 1 to 10 µM (i.e. around the IC 50 of CdA in EHEB cells [12] ) after a 24-h incubation (Fig. 1A ). In agreement with our preliminary data [13] , we observed that CdA reduced the p21 protein level in a dosedependent manner, this effect being detectable at the lowest concentration tested, whereas p53
was up-regulated. Analysis of the time effect at 10 µM CdA showed that the depletion of p21
did not start immediately after adding the nucleoside (Fig. 1B) , but required about 4 h to become apparent. Densitometric quantification showed that p21 depletion could reach 80% of control after a 24h-incubation with CdA.
To probe the signaling from p53 to p21 in EHEB cells, we analyzed the p21 protein level in cells treated with nutlin-3a, a non-genotoxic agent that activates p53 by antagonizing its negative regulator MDM2 [24, 25] . Nutlin-3a up-regulated p53 and increased the p21 protein level in contrast to CdA that induced p21 depletion (Fig. 1C) . We also tested the effect of various non-nucleosidic DNA-damaging agents known to activate p53, including UV irradiation, which was shown in several reports to down-regulate p21 regardless of p53 accumulation [15] [16] [17] [18] . We found that the p21 level was strongly reduced 8 h after UV irradiation, but increased after incubation with etoposide, a topoisomerase inhibitor, or A c c e p t e d M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   9 doxorubicin, an anthracycline. These results demonstrate that p21 is able to increase above its basal level in EHEB cells, though certain genotoxic stress conditions elicit p21 depletion.
p21 depletion is triggered by various nucleoside analogs in the CLL cell lines EHEB and JVM-2
Next, we investigated whether other NAs can induce p21 depletion in EHEB cells. We examined the effect of fludarabine, another purine analog used in CLL. Like CdA, fludarabine caused a marked depletion of p21 protein, which was almost maximal at 5 µM, despite evident accumulation of p53 ( Fig. 2A) . We then analyzed the effect of the pyrimidine analogs gemcitabine (dFdC) and cytarabine (Ara-C), which are drugs used in the treatment of solid and hematological tumors. Gemcitabine and cytarabine, at concentrations found to be cytotoxic for EHEB cells (unpublished results), also induced dose-dependent p21 depletion despite p53 activation (Fig. 2B ).
We then examined if this peculiar effect of NAs might be observed in other cell lines.
We selected JVM-2 cells, a CLL cell line with intermediate sensitivity to CdA (IC 50 ~ 0.5 µM). CdA, fludarabine (Fig. 2C) , gemcitabine, and cytarabine ( Fig. 2D ) were found to reduce the level of p21 protein in JVM-2 cells, like in EHEB cells, though p53 was activated. In contrast, in lymphocytes freshly isolated from CLL patients, the p21 protein level increased after CdA treatment (Supplementary data, Fig. S1 ), as reported previously [26] .
Purine analogs promote proteasomal degradation of p21 in CLL cell lines
Impaired p21 accumulation after p53 induction could be due to multiple cellular mechanisms, including a failure to up-regulate mRNA synthesis, as observed after treatment with hydroxyurea or aphidicolin [27] , or enhanced proteolysis, as observed in some UV irradiation conditions [15] [16] [17] .
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The influence of purine analogs on p21 gene transcription was analyzed using qPCR.
EHEB cells were incubated for 24 h with 10 µM nutlin-3a as a positive control and CdA or fludarabine at two concentrations (Fig. 3) . The expression of p21 mRNA was up-regulated by more than 4-fold in cells treated with nutlin-3a and dose-dependently, up to 4-fold, in the presence of CdA or fludarabine. These results demonstrate that the expression of p21 mRNA is enhanced by purine analogs in EHEB cells and, therefore, that the p21 depletion observed under these conditions does not result from inhibited gene transcription, but rather increased protein degradation.
To verify this hypothesis, we measured the p21 protein half-life. EHEB cells were pre- (Fig. 4B ).
The p21 protein is known to be regulated by the proteasome system [28] . To verify that NAs promote proteosomal turnover of p21, we analyzed the effect of proteasome inhibitors MG-132 and LLnL on the p21 depletion induced by CdA or fludarabine in EHEB cells. Inhibiting proteasome activity led to an increase in the basal level of p21 protein, but also prevented the depletion of p21 observed after exposure of the cells to CdA or fludarabine (Fig. 5A) . The same results were obtained in JVM-2 cells (data not shown).
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CdA [12] . However, the pan-specific caspase inhibitor Z-VAD-fmk was unable to prevent the CdA-induced depletion of p21 (Fig. 5B) . All of these data indicate that the depletion of p21
induced by CdA and fludarabine in CLL cell lines results from enhanced degradation through the proteasome pathway.
p21 degradation induced by nucleoside analogs is ubiquitin-independent
The proteasomal degradation of p21 has been reported to occur by both ubiquitin-dependent and ubiquitin-independent pathways [31] [32] [33] [34] . Therefore, we analyzed the effect of NAs on p21 ubiquitination by immunoblotting with an anti-ubiquitin antibody after immunoprecipitating p21. We first investigated the effect of 10 µM CdA on p21 ubiquitination in EHEB cells incubated with or without the proteasome inhibitor MG-132.
After 8-h incubation with or without CdA, p21 ubiquitination was not detected in the absence of MG-132, even after a long film exposure (Fig. 6A) . In contrast, p21 ubiquitination was 
p21 depletion induced by nucleoside analogs is associated with Cdk2 activation and
PCNA monoubiquitination
The first recognized, and one of the most studied, role of p21 is its ability to induce cell cycle arrest after DNA damage. This effect is primarily mediated through the inhibition of Cdk2, the major kinase that allows progression from G1 to S-phase [35] . Our previous observation 12 that CdA did not block the cell cycle at the G1/S transition in EHEB cells, but promoted the entry of cells into S-phase [12, 13] , and the present finding that the p21 level was reduced by CdA ( Fig. 1 ) strongly suggested that Cdk2 activity might be enhanced in EHEB cells following CdA treatment. We assessed the Cdk2 activity by measuring its ability to phosphorylate histone H1. As predicted, we observed that CdA induced a time-and dosedependent ( Fig. 7A and B ) increase in Cdk2 activity in EHEB cells. We also found that the Cdk2 activity was augmented in EHEB cells incubated for 24 h with fludarabine, gemcitabine, or cytarabine, though to a lesser extent than the change in activity observed with CdA ( Fig. 7C) . On the contrary, Cdk2 activity was completely abolished in EHEB cells incubated with etoposide, doxorubicin and nutlin-3a, which induced strong p21 accumulation (data not shown). CdA and fludarabine also up-regulated Cdk2 activity in JVM-2 cells (Supplementary data, Fig. S2 ).
In addition to associating with Cdk2 and other Cdks, p21 can bind to PCNA, a homotrimeric protein complex that forms a ring around double-stranded DNA and plays an essential role in both DNA replication and repair [36, 37] . The interaction of p21 with PCNA has been shown to inhibit several PCNA functions in vitro, notably PCNA-dependent replication and the resynthesis step of nucleotide excision repair (NER) [18, [38] [39] [40] . In line with the latter finding, p21 depletion after UV irradiation has been shown to promote PCNAdependent DNA repair and suggested to play a critical role in the cellular response to UVinduced DNA damage [15] . Though the role of p21 in NER in vivo is still being debated, recent reports indicate that p21 down-regulation may promote DNA repair by translesion DNA synthesis (TLS), a process that allows DNA lesions to be bypassed [18, 40, 41] . In particular, p21 was demonstrated to be a negative regulator of PCNA monoubiquitination after UV irradiation [18] . This posttranslational modification is essential for the interaction of PCNA with DNA polymerase , a TLS-specific polymerase that can replicate past damaged A c c e p t e d M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 13 templates and trigger TLS [42] . Therefore, we sought to analyze whether the NA-induced depletion of p21 might elicit PCNA monoubiquitination. Monoubiquitinated PCNA can be detected by SDS-PAGE as a slowly migrating form of PCNA, the molecular weight of which is increased by approximately 10 kDa, corresponding to a single ubiquitin bound to PCNA [21] . In accordance with our hypothesis, we found that treatment with CdA induced a higher molecular weight form of PCNA in a time-and dose-dependent manner ( Fig. 8A and B) , indicating that PCNA was monoubiquitinated. Similarly to CdA, fludarabine, gemcitabine,
and Ara-C also caused PCNA monoubiquitination (Fig. 8C) . In contrast, PCNA was not monoubiquitinated after exposing the cells to nutlin-3a or etoposide. The same results were observed in JVM-2 cells (Fig. 8D) . We verified in additional experiments that PCNA was also monoubiquitinated after UV-irradiation (50 J/m2) consistently with previous reports [18, 21] , but not after doxorubicin (1 µM), in both EHEB and JVM-2 cells (data not shown).
DISCUSSION
The present study demonstrates that CdA as well as other NAs can down-regulate p21 in CLL cell lines, which constitutes a still unexplored response to this class of chemotherapeutic agents. The down-regulation of p21 by CdA in EHEB cells was unexpected because CdA and also fludarabine have previously been shown to induce p21 accumulation in response to p53 activation in various cell types, including freshly isolated CLL lymphocytes [22, 26, [43] [44] [45] .
However, our reproducible results with four different NAs in two different cell lines show that this p21 depletion is not a fortuitous effect. Therefore, NAs can be added to the list of genotoxic agents that, as recently emphasized by Soria and Gottifredi [46] , do not comply in some cell models with the dogma stating that DNA damage activates p53 to trigger p21 accumulation. Among these agents are UV-irradiation, cisplatin, and methyl methane A c c e p t e d M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 14 sulfonate, which all block replication forks [46] , but also ionizing radiation, which induces DNA double-strand breaks [47] .
Since p21 mRNA is clearly increased after NA treatment, NA-induced p21 depletion cannot result from a failure to up-regulate p21 transcription. Instead, as shown by the results obtained in the presence of proteasome inhibitors, NAs appear to promote the degradation of p21 via the proteasome pathway. Proteasomal p21 degradation can occur through both ubiquitin-dependent and independent pathways, under basal as well as stress conditions [40, 46, 48, 49] . Although the pathway implicated in the UV-induced p21 depletion is debated [15, 16] , this process is now thought to be ubiquitin-dependent because it has been shown to require CRL4 Cdt2 E3 ubiquitin ligase activity [50, 51] . We were not able to detect increased p21 ubiquitination after incubating the cells with NAs, suggesting that NA-induced proteasomal p21 degradation occurs via an ubiquitin-independent pathway. This could be mediated by direct interaction between p21 and the C8-subunit of the 20S proteasome [32] , a process that can been promoted by MDM2 and/or MDMX [52] [53] [54] , as well as by 14-3-3 as recently discovered [55] . Phosphorylation also is known to regulate the stability of the p21
protein [56] . Accordingly, UV-induced p21 proteolysis appears to be mediated by phosphorylation at Ser114 by the kinase GSK-3 activated by the ATR signaling pathway [17] . In our study, we did not observe any effect of various ATR or GSK-3 inhibitors on NA-induced p21 degradation (data not shown). Therefore, the signal pathway by which NAs trigger proteasomal p21 degradation remains to be elucidated.
As a rule, the cell cycle is arrested after DNA damage as the result of p53 induction, transcription of its target gene p21, accumulation of the p21 protein, and the inhibition of Cdk2 activity [35] . Accordingly, fludarabine has been shown to inhibit Cdk2 in ML-1 cells following induction of p53 [22] . In contrast, our results consistently showed that NAs, particularly CdA, increase Cdk2 activity in CLL cell lines. Nevertheless, even if p21 M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 15 depletion releases a block [57] , we cannot currently attest that this event is enough to trigger Cdk2 activation. Indeed, a number of other factors could be involved in the activation of Cdk2, including changes in the phosphorylation state or in the binding to cyclins or p27 [58] .
Studies are in progress to examine which event really determines NA-induced Cdk2 activation in our cell models. The physiological implication of Cdk2 activation by NAs also remains to be elucidated. This activation likely explains our previous observation that CdA promotes G1/S progression in EHEB cells [12, 13] , but a role in apoptosis [59] or DNA repair [60] cannot be excluded.
In addition to its role in cell cycle control, p21 can assume both pro-or anti-apoptotic functions in response to anti-tumor agents, depending on the cell type and cellular context (reviewed in [61] ). Previous studies have shown that HCT116 cells, in which the p21 gene has been deleted through homologous recombination, are ~4-fold less sensitive to CdA than wild-type HCT116 cells [43] . These data suggest that the NA-induced depletion of p21 in CLL cell lines may contribute to decrease cell sensitivity to NAs. Our observation that p21 depletion is accompanied by PCNA monoubiquitination supports this hypothesis. Indeed, PCNA monoubiquitination stimulates the recruitment of polymerase , a polymerase involved in DNA damage tolerance at stalled DNA replication forks. This recruitment promotes TLS, a process that avoids the replication block during S-phase and favors DNA repair and cell survival. TLS has been consistently implicated as a potential mechanism of resistance to cisplatin treatment [62] . More recently, studies conducted with polymerase -deficient fibroblasts have shown that these cells are more sensitive to chemotherapeutic agents, including gemcitabine and cytarabine, indicating that polymerase , and thus TLS, can indeed modulate cell sensitivity to NAs [63] . Further work is needed to determine whether PCNA monoubiquitination could play a role in the clinical resistance to NAs, an almost universal phenomenon in patients suffering from CLL.
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A c c e p t e d M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 To conclude, we identified two distinct cellular stress reactions in response to DNA damaging agents in the CLL cell lines EHEB and JVM-2 with on one hand, p21 depletion, Cdk2 activation and PCNA monoubiquitination triggered by NAs, and on the other hand p21 accumulation, Cdk2 inhibition and no change in PCNA monoubiquitination after etoposide and doxorubicin. These opposite patterns of cell behavior towards p53 inducers might be related to the different nature of DNA lesions. Importantly, potential discrepancies in p53 and p21 protein up-regulation should be taken into account in the assays that measure p21 protein expression as a tool to probe the functionality of the p53 pathway [64] .
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